Nucala's approval offers hope for uncontrolled COPD. This new drug reduces flare-ups, a key benefit for Black Americans.

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

For over a decade, Sidney resident Leo Levasseur has been a vocal advocate for banning the sale of cigarettes in British ...

Sanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.

TIRUCHY: From June 4, all 84 primary health centres (PHCs) in the district, including those under the corporation, will ...

Introduction Both stable chronic obstructive pulmonary disease (COPD) and acute exacerbations represent leading causes of death, disability and healthcare expenditure. They are complex, heterogeneous ...

Paris: Sanofi has announced that the AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately ...

Machine learning models using data from digital inhalers can successfully predict COPD exacerbations up to 5 days in advance.